CNBX Pharmaceuticals Inc.
OTC: CNBX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Eyal Barad
- Employees
- 1
- Headquarters
- Bethesda, United States
- IPO year
- 2007
- Market cap
- $18.5K
- Website
- https://www.cnbxpharma.com
Loading CNBX…
Loading profile data…Frequently asked questions about CNBX
What does CNBX Pharmaceuticals Inc. (CNBX) do?
CNBX Pharmaceuticals Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing cannabinoid-based treatments and therapies for various cancers. Its flagship product candidate, RCC-33, is an oral capsule formulation of cannabinoids specifically engineered for treating colorectal cancer. The company's development pi...
Where does CNBX trade?
CNBX Pharmaceuticals Inc. (CNBX) trades on the Other OTC.
What sector is CNBX in?
CNBX Pharmaceuticals Inc. (CNBX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of CNBX Pharmaceuticals Inc.?
Eyal Barad is the chief executive officer of CNBX Pharmaceuticals Inc. (CNBX).
Where is CNBX Pharmaceuticals Inc. headquartered?
CNBX Pharmaceuticals Inc. is headquartered in United States.
Does CNBX pay a dividend?
CNBX Pharmaceuticals Inc. (CNBX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CNBX go public?
CNBX Pharmaceuticals Inc. (CNBX) completed its initial public offering in 2007.